Patient Partner Involvement in Research

Throughout the website, we use the Patient-Centered Outcomes Research Institute (PCORI)’s definition of patient partners, which includes patients (those with lived experience), family members, caregivers, and the organizations that are representative of the population of interest in a particular study.

The significance of patient partner involvement in research is widely recognized. It enhances the effectiveness of clinical and medical research, ensuring outcomes meet patients’ needs. By collaboratively identifying and understanding unmet needs, and incorporating patient input throughout clinical trials, we improve the development and evaluation of new treatments.

Learn more about the process of implementing patient partner involvement in research: Research Involvement and Engagement.

Guidance to the application requirements are divided in:

Step 1: Pre-Application Grant

Grants up to USD 4,000 that aim to bridge the funding gap for patient partners who contribute to developing a study question that can be submitted as a letter of intent to RTFCCR. This award is designed to cover travel costs for preparatory meetings and to compensate patient partners for their time.

Step 2: Choice of Patient Partner Involvement Model in Research Projects

Applicants must provide a detailed explanation justifying the selected patient partner role for the project. Please refer to our description of patient partner roles in the funding guidelines.

Step 3: Patient Partner Involvement in Research Planning Checklist

This checklist highlights key Patient Partner Involvement in Research points to consider during the application phase, project implementation, and beyond. For more information, please refer to our funding guidelines.

Step 4: Completing the Patient Partner Involvement in Research Plan Template

The plan should outline Patient Partner Involvement in Research processes during both the project application generation and implementation phases. It should describe the collaboration, clearly describe expected outputs, and explain how patient partner input will be processed and incorporated. Please download the plan template here.

Step 5: Review of Applications by Patient Partners

In addition to the Patient Partner Involvement in Research Plan, applicants must answer a set of questions to give patient partners reviewing each application a clearer understanding of the addressed patient needs and how they are being met.

Webinar series​

Partnering with Patients to Improve Clinical Trials

We invite you to watch our webinar series, developed in partnership with the LUNGevity Foundation, to explore the vital role that people with cancer can play in developing clinical trials. Through engaging panelist presentations and discussions, these webinars highlight flagship collaborations from both the patient partner’s and the researcher’s perspectives.
 

In the first episode of our series, we highlight a collaboration between a patient partner and a clinician aimed at developing patient-centric endpoints for a geriatric prostate cancer clinical trial.

The second episode of our webinar series demonstrates how researchers and patient partners can co-design clinical trials that truly resonate with patients and address their most pressing concerns. Based on insights from the lung cancer community.

The third episode of our webinar series illustrates the transformative impact of patient partner involvement in the research process. By examining the POSITIVE study, a breast cancer-focused clinical trial, we explore real-world examples of successful patient partner-researcher collaborations.

Patient Partner Involvement in Underserved Areas

This grants program, initially focused on Uganda and Kenya, has served as a pioneering initiative to advance clinical cancer research for rapid impact on patient outcomes in sub-Saharan Africa. It has also enhanced the capacities of applicants from these countries, empowering them to effectively compete as leading investigators for global research opportunities in the future. We are sharing the lessons learned in patient engagement from this pilot so they can serve as exemplary models for other African countries.

Read more about this initiative: Advancing Cancer Research in Sub-Saharan Africa.

Patient Involvement Materials

DIA considerations guide to implementing patient-centric initiatives in health care product development

Recommendations on patient involvement for funding institutions

Recommendations on patient involvement for applicants of collaborative research grants

Recommendation for patient organizations and patient advocates on their involvement in collaborative research projects

Empfehlungen Patientenorganisationen und Patientenvertreter zur Beteiligung an kollaborativen Forschungsprojekten

Adopting recommendations for implementing patient involvement in cancer research a funder’s approach

The Rising Tide Foundation and Patvocates have jointly developed guidance documents to support public and private health research funding institutions, research teams, and patient organizations with recommendations on organizational models, potential patient community contributions, checklists, and templates that support patient involvement in the generation of calls for proposals, the preparation and review of grant applications, and the implementation of research projects.

These recommendations are based on patient engagement models and methodologies established by leading collaborative initiatives, such as EUPATI, PFMD, PARADIGM and INVOLVE; interviews of patient engagement experts in patient organizations, funding institutions, regulatory authorities and academic institutions in the USA and Europe; as well as practical experience of patient advocates in the Patvocates team.

Funding Opportunities

Open Call

We accept letter of intent (LOIs) all year round and do not have specific deadlines. Once you have submitted your LOI, you will receive further information regarding timing and next steps.

Pre-application Grants

Pre-application grants provide gap funding to support patient experts’ helping to develop grant applications/ protocols.

Focus Areas

Scroll to Top

Identifying Clinically Relevant Endpoints People Actually Care About​

The first webinar features our grantee Dr. Shabbir Alibhai, professor of Medicine at the Princess Margaret Cancer Centre and University of Toronto; Janet Freeman-Daily, co-founder and president of the ROS1ders; and Winston Klaas, past chairman and associate director of Prostate Cancer Support Toronto. It is hosted by Dr. Upal Basu Roy, LUNGevity’s executive director of Research. You can watch the entire conversation or use the timestamps below to find specific topics of interest.  

Panelist Introductions: 0:00 – 3:59  

  • Dr. Shabbir Alibhai, professor of Medicine at the Princess Margaret Cancer Centre and University of Toronto;   
  • Janet Freeman-Daily, co-founder and president of the ROS1ders;   
  • Winston Klaas, past chairman and associate director of Prostate Cancer Support Toronto.   

Researcher Insights: 4:00 – 19:50  
Dr. Alibhai speaks about how his team has conducted three studies that involved patients in clinical trial design. He shares his experiences and learnings from working closely with patients to understand their perspectives.  

Patient Insights: 19:43 – 31:30  
Winston Klaas talks about being a patient and being part of the clinical trial design process. He shares his tips and key considerations for how researchers can engage with patients successfully.   

Discussion: 31:30 – 55:49  
In a discussion led by Janet Freeman-Daily, the panelists unearth important details about effective collaboration. Their conversation highlights key skills for researchers and for patients to use when successfully collaborating on research studies. 

Developing Clinical Trials that Account for the Realities of Patient Life

In this second video, LUNGevity again partnered with Rising Tide for Clinical Cancer Research to show how researchers and patient advocates can be empowered with tools to create clinical trials that resonate with patients and address the key issues they care about.

Introductions: 0:00 – 3:22
Meet moderator Karolina Werynska, PhD, scientific program manager for Rising Tide Foundation for Clinical Cancer Research, as she introduces the panelists.

  • Janet Freeman-Daily, patient research advocate and co-founder of ROS1ders
  • Ross Camidge, MD, PhD, professor of medicine-medical oncology at the University of Colorado

Laying the Groundwork for Patient Involvement: 3:22 – 14:29
Panelists explain what interventional clinical trials are—studies of the safety and effectiveness of a treatment—and how patients can get involved in providing guidance and feedback. The panelists also offer examples of why the patient perspective is so important.

Helping Researchers Find Patient Partners: 14:30 – 23:48
In an open discussion, panelists offer suggestions for how researchers can find patients interested in getting involved in research. They provide real-world examples of researchers who have adjusted their clinical trial protocols based on patient feedback. In addition, they offer a deeper understanding of how much patient input is realistically possible to incorporate in clinical trial design.

Addressing FAQs for Researchers 23:49 – 31:15
Panelists discuss the timeline and planning needed to optimally involve patients in clinical trial design. They underscore the need for more patients to get involved in developing clinical trials and offer an example of a great community-wide effort in lung cancer to engage patients.

Wrap-up Discussion and Key Takeaways 31:16 – 41:10
Here the panelists discuss the importance of using patient-centric endpoints in clinical trials. They also offer resources for researchers and patients interested in learning more about collaborating on clinical trial design.

Designing clinical trials: Learnings from breast cancer research

In the final video in our three-part series, LUNGevity and Rising Tide for Clinical Cancer Research partnered again to illustrate the power of having patients contribute to the research process. We use a real-world example to learn about patient-researcher collaborations through the POSITIVE study, a breast cancer-focused clinical trial.

Introductions: 0:00 – 1:54
Meet moderator Alexandre Costa Alencar, MD, head of cancer research programs at Rising Tide Foundation for Clinical Cancer Research, as he establishes the goals of this webinar series and introduces the panelists.

  • Teresa Ferriero, PhD, patient partner of the POSITIVE study
  • Olivia Pagani, MD, scientific chair of the POSITIVE study
  • Monica Ruggeri, operational lead of the POSITIVE study

Explaining the POSITIVE study: 2:10 – 5:59
Learn more about the POSITIVE study, an international clinical trial of 500 patients, to understand its important goals. 

How the Collaboration Began: 6:00 – 10:52
The panelists emphasize the importance of the POSITIVE study and discuss how initial patient survey data allowed the researchers to begin the study design process with patients’ needs in mind.

Examples of Empowering Patients: 10:53 – 25:17
Here the panelists discuss the roles of patient involvement in many aspects of the POSITIVE clinical trial—including participation in the steering committee, fundraising events, and dissemination of study results. 

Effective Involvement of Patients: 25:18 – 50:25
Researchers share their key considerations when choosing patients to collaborate with. They also note that it’s time-consuming to identify the right patients and build these relationships—but the investment is worth the impact. Don’t miss this frank discussion as the panelists explain their expectations from the collaboration process, such as including financial compensation and emotional fulfillment.

Wrap-up Discussion and Key Takeaways: 50:26 – 59:10
Panelists discuss the biggest learnings and challenges from collaborating on the POSITIVE study and offer final tips for successful patient-researcher partnerships.